Infliximab in inflammatory bowel disease

Anti-tumor necrosis factor (TNF) therapy has revolutionized the medical treatment of the inflammatory bowel diseases (IBD), Crohn's disease (CD), and ulcerative colitis. Twenty years ago, infliximab became the first anti-TNF agent approved for IBD. Data from randomized controlled trials, large...

Full description

Saved in:
Bibliographic Details
Main Authors: Konstantinos Papamichael (Author), Steve Lin (Author), Matthew Moore (Author), Garyfallia Papaioannou (Author), Lindsey Sattler (Author), Adam S. Cheifetz (Author)
Format: Book
Published: SAGE Publishing, 2019-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available